Literature DB >> 36003365

Cerebral venous sinus thrombosis as a complication of cranial melioidosis - a rare case report.

Biji Bahuleyan1, Manuel Adarsh1, Jayachandran Akarsh1, Arun Kumar M L2, Chandra S Rohitha3, George Xavier Elenjickal4, Sreevalsan T V5, Santhosh George Thomas1.   

Abstract

Cerebral venous sinus thrombosis is a rare complication of cranial melioidosis. We report a case of an adult male who presented with skull osteomyelitis, transverse sinus thrombosis and multiple brain abscesses. His blood cultures grew Burkholderia pseudomallei . The patient finally succumbed after multiple recurrences of the infection despite surgical excision of the osteomyelitic bone and the recommended antibiotic treatment. The management of cerebral venous sinus thrombosis in patients with cranial melioidosis is discussed along with a brief review of the literature.
© 2022 The Authors.

Entities:  

Keywords:  Burkholderia pseudomallei; cerebral abscess; cerebral venous sinus thrombosis; melioidosis; osteomyelitis

Year:  2022        PMID: 36003365      PMCID: PMC9394529          DOI: 10.1099/acmi.0.000357

Source DB:  PubMed          Journal:  Access Microbiol        ISSN: 2516-8290


Introduction

Melioidosis is an infection caused by the soil-dwelling Gram-negative organism, [1, 2]. Infection of the central nervous system (CNS) by this organism, known as cranial melioidosis (CM) is rare [1, 3]. CM can involve any structure in and around the CNS [1, 2, 4]. The case we present is novel in that simultaneous occurrence of skull osteomyelitis, cerebral venous sinus thrombosis (CVT), multiple cerebral abscesses and systemic melioidosis in the same patient, is a clinical entity that has not been reported so far. Our case is also the fifth reported case of CVT in a patient with CM.

Clinical presentation

This 51-year-old male patient with diabetes mellitus (DM) was admitted six times at our centre for treatment, the details of which are summarized in Table 1. He had multiple admissions as there was recurrence of infection despite recommended treatment during each of these admissions.
Table 1.

Details of the multiple hospital admissions

Admission

History and examination

Brain imaging

Blood investigations

Treatment

Course

First

Fever, HA, retro mastoid swelling

CT: Erosion of skull near Lt TS and adjacent soft tissue swelling (Fig. 1a)

MRI and MRV: Contrast enhancement involving the dura, occipital bone and overlying scalp (Fig. 1b), Lt TS thrombosis (Fig. 1c)

Blood C/S : negative for AFB, fungal and routine.

CSF study: normal

Empirical: IV VAN, CFP-TAZ x 3 wks f/b IV CZM x 2 wks (as renal parameters worsened) f/b P/O CIP x 2 wks (Total 7 wks)

Denied surgical excision

Improved

Second (3 wks after d/d)

Fever, retro mastoid swelling

MRI: Same as first admission

Blood C/S: Pseudomonas aeruginosasensitive PIP-TAZ, LEV, MEP, CZM, CFP, CIP

PIP-TAZ x 2 wks

Denied surgical excision

Improved

Third (4 wks after d/d)

Altered sensorium

MRI: Extension of the bony and soft tissue swelling

Blood C/S: B. pseudomallei sensitive to CZM, MEP, MIN, TMP-SMX

Histopathology: Chronic osteomyelitis

Sx :Excision of the osteomyelitic occipital bone.

IV CZM (renal adjusted dose) x 3 wks f/b MEP (renal adjusted dose) x 5 wks. P/O TMP-SMX and MIN x 24 wks

Improved

Fourth (36 wks after d/d)

Fever, Lt hemiparesis

MRI: Multiple contrast enhancing lesions involving both cerebral hemispheres, cerebellum and brain stem (Fig. 2a, b)

Blood and urineC/S: Sterile

IV CZM, MTG, VAN (renal adjusted dose) x 2 wks

P/O MIN and LEV x 6 wks

Improved

Resolution of brain abscesses on MRI

Fifth (12 wks after d/d)

Fever, GTCS, Lt hemiparesis

MRI: Right frontoparietal T2 weighted hyperintense lesion

Blood and urine C/S: Sterile

AMX-CLV x 2 wks

Worsened

Sixth (6 wks after d/d)

Lt hemiparesis

MRI: Right frontoparietal white matter contrast enhancing lesion (Fig. 2c)

Not done as they refused

MIN and LEV

Lost to FU

Expired 8 wks after the last FU

wks weeks, d/d discharge, GTCS generalized tonic clonic seizure, Lt left, HA headache, CT computed tomography, MRI magnetic resonance imaging, MRV magnetic resonance venogram, TS transverse sinus, AFB acid fast bacilli, CSF cerebrospinal fluid, VAN vancomycin, CFP cefepime, TAZ tazobactam, CZM ceftazidime, IV intravenous, P/O per oral, C/S culture and sensitivity, PIP-TAZ piperacillin and tazobactam, MEP meropenem, MIN minocycline, TMP-SMX co-trimoxazole, MTG metrogyl, CIP ciprofloxacin, LEV levofloxacin, AMX-CLV amoxicillin and clavulanic acid, FU follow up, Sx surgery, f/b followed by.

Details of the multiple hospital admissions Admission History and examination Brain imaging Blood investigations Treatment Course First Fever, HA, retro mastoid swelling CT: Erosion of skull near Lt TS and adjacent soft tissue swelling (Fig. 1a)
Fig. 1.

(a) The axial view of CT bone window of the skull showing bony erosion near the left TS and adjacent soft tissue swelling (white arrowhead). (b) The axial view of contrast MRI scan of the brain showing enhancement involving the dura, occipital bone and overlying scalp (empty arrow). (c) The coronal MIP reformation of MR venogram of the brain showing Lt TS thrombosis (white arrow).

MRI and MRV: Contrast enhancement involving the dura, occipital bone and overlying scalp (Fig. 1b), Lt TS thrombosis (Fig. 1c) Blood C/S : negative for AFB, fungal and routine. CSF study: normal Empirical: IV VAN, CFP-TAZ x 3 wks f/b IV CZM x 2 wks (as renal parameters worsened) f/b P/O CIP x 2 wks (Total 7 wks) Denied surgical excision Improved Second (3 wks after d/d) Fever, retro mastoid swelling MRI: Same as first admission Blood C/S: Pseudomonas aeruginosasensitive PIP-TAZ, LEV, MEP, CZM, CFP, CIP PIP-TAZ x 2 wks Denied surgical excision Improved Third (4 wks after d/d) Altered sensorium MRI: Extension of the bony and soft tissue swelling Blood C/S: sensitive to CZM, MEP, MIN, TMP-SMX Histopathology: Chronic osteomyelitis Sx :Excision of the osteomyelitic occipital bone. IV CZM (renal adjusted dose) x 3 wks f/b MEP (renal adjusted dose) x 5 wks. P/O TMP-SMX and MIN x 24 wks Improved Fourth (36 wks after d/d) Fever, Lt hemiparesis MRI: Multiple contrast enhancing lesions involving both cerebral hemispheres, cerebellum and brain stem (Fig. 2a, b)
Fig. 2.

(a) The axial view of contrast MRI scan of the brain showing multiple contrast enhancing lesions involving the right cerebral hemisphere (white arrowhead). (b) The axial view of contrast MRI scan of the brain showing contrast enhancing lesion in the brainstem (empty arrow). (c) The axial view of contrast MRI scan of the brain showing right frontoparietal white matter contrast enhancing lesion (white arrow).

Blood and urineC/S: Sterile IV CZM, MTG, VAN (renal adjusted dose) x 2 wks P/O MIN and LEV x 6 wks Improved Resolution of brain abscesses on MRI Fifth (12 wks after d/d) Fever, GTCS, Lt hemiparesis MRI: Right frontoparietal T2 weighted hyperintense lesion Blood and urine C/S: Sterile AMX-CLV x 2 wks Worsened Sixth (6 wks after d/d) Lt hemiparesis MRI: Right frontoparietal white matter contrast enhancing lesion (Fig. 2c) Not done as they refused MIN and LEV Lost to FU Expired 8 wks after the last FU wks weeks, d/d discharge, GTCS generalized tonic clonic seizure, Lt left, HA headache, CT computed tomography, MRI magnetic resonance imaging, MRV magnetic resonance venogram, TS transverse sinus, AFB acid fast bacilli, CSF cerebrospinal fluid, VAN vancomycin, CFP cefepime, TAZ tazobactam, CZM ceftazidime, IV intravenous, P/O per oral, C/S culture and sensitivity, PIP-TAZ piperacillin and tazobactam, MEP meropenem, MIN minocycline, TMP-SMX co-trimoxazole, MTG metrogyl, CIP ciprofloxacin, LEV levofloxacin, AMX-CLV amoxicillin and clavulanic acid, FU follow up, Sx surgery, f/b followed by. (a) The axial view of CT bone window of the skull showing bony erosion near the left TS and adjacent soft tissue swelling (white arrowhead). (b) The axial view of contrast MRI scan of the brain showing enhancement involving the dura, occipital bone and overlying scalp (empty arrow). (c) The coronal MIP reformation of MR venogram of the brain showing Lt TS thrombosis (white arrow). (a) The axial view of contrast MRI scan of the brain showing multiple contrast enhancing lesions involving the right cerebral hemisphere (white arrowhead). (b) The axial view of contrast MRI scan of the brain showing contrast enhancing lesion in the brainstem (empty arrow). (c) The axial view of contrast MRI scan of the brain showing right frontoparietal white matter contrast enhancing lesion (white arrow). In the first admission, contrast computed tomogram (CT) of the brain showed imaging features suggestive of focal osteomyelitis of the left occipital bone near the transverse sinus (Fig. 1a). Magnetic resonance imaging (MRI) of the brain showed focal pachymeningitis in the left occipital region (Fig. 1b). Magnetic resonance venogram showed left transverse sinus (TS) thrombosis (Fig. 1c). Blood and cerebrospinal fluid (CSF) cultures were sterile. Excision, biopsy and culture of the occipital bony lesion was planned. Patient and relatives were unwilling for any surgical procedure. Hence he was started on empirical intravenous antibiotics followed by oral antibiotics for a total duration of 7 weeks along with antiepileptic medications and blood thinners. He became afebrile and the retromastoid swelling subsided. During the second admission, blood culture grew . He was treated with culture specific intravenous antibiotics for 2 weeks with which he improved clinically. He presented in a state of altered sensorium during the third admission. MRI of the brain showed progression of the bony erosion. He underwent left retromoastoid craniectomy and excision of the osteomyelitic occipital bone. The histopathology of the bone specimen was suggestive of chronic osteomyelitis. Blood culture grew . He was started on culture-specific intravenous and oral antibiotics simultaneously. Intravenous antibiotics were given for 8 weeks and the oral antibiotics were continued for a total of 24 weeks. He remained asymptomatic for about 36 weeks from the time of discharge. During the fourth admission, he presented with left hemiparesis. MRI of the brain showed multiple contrast enhancing ill-defined lesions involving grey and white matter of both cerebral hemispheres, cerebellum and brain stem (Fig. 2a, b). Blood and urine cultures were sterile. He was treated with empirical intravenous followed by oral antibiotics based on the previous positive culture sensitivity for a total of 6 weeks. His general condition and hemiparesis improved. During the fifth and sixth admissions, the MRI of the brain showed progression of the ill-defined lesions with development of a large enhancing lesion in the right frontoparietal white matter (Fig. 2c). Blood and urine cultures remained sterile. He was treated with empirical antibiotics but lost to follow up and subsequently expired.

Discussion

Melioidosis is endemic in Southeast Asia and Northern Australia [3]. Infection with this organism occurs via ingestion, inhalation or percutaneous inoculation [2, 3]. CNS infection is believed to be secondary to hematogenous spread or direct spread from the nasopharynx [2]. Melioidosis can affect any organ of the body and it can cause blood-stream infections (septicemia) as seen in our case. The organism is known to cause scalp abscess [4], pachymeningitis [4], skull osteomyelitis [1], cerebral abscesses [1], cranial subdural empyema [2], meningoencephalitis [5], meningitis [4], encephalomyelitis [2] or CVT [4, 6–8]. Encephalomyelitis is the presentation with the worst prognosis [2]. When melioidosis involves the spinal cord a wrong diagnosis of demyelination can often lead to the initiation of steroids, which can be detrimental [2]. In reported cases of CM with CVT the CNS involvement includes venous infarct [8], cerebral abscess [6, 7], cerebellar abscess [6], subdural collection [7], pachymeningeal thickening [4] and skull osteomyelitis [7]. Involvement of multiple tissue layers from the scalp to the brain parenchyma as reported by Pit et al. was seen in our case [9]. The previously reported four cases of CM with CVT and the case we present are summarized in Table 2. Niyasom et al. reported the first case of CM with CVT [8]. Patients with CM with CVT can have associated venous infarction in the cerebral hemispheres [8]. All patients were males with ages ranging from 23 to 69 [4, 6–8]. The commonest co-morbidity associated was DM [6, 8, 10]. The other risk factors include renal disease, thalassemia, previous trauma or surgery, pulmonary tuberculosis and malignancies [10]. Our patient had both DM and renal failure as co-morbidities. The venous sinus commonly involved was the superior sagittal sinus [6-8]. Two previously reported cases [4, 8] showed TS involvement as seen in our case.
Table 2.

Cases of CM associated with CVT [4, 6–8]

Author

Age/sex

Co-morbidities

CVT location

Other CNS involvement

Treatment

Outcome (FU wks)

Niyasom et al. [8]

42 /M

DM, liver cirrhosis

SSS,TS, SS

Parietal lobe infarct

CZ x 2 wks

Improved (2 wks)

Nayak et al. [4]

23 /M

Nil

TS, SS, jugular vein

Pachymeningeal thickening temporal region and petrous apex

Biopsy f/b IV CZ x 6 wks f/b P/O TMP-SMX x 24 wks

Improved

(24 wks)

Abeysundara et al. [6]

69 /M

DM

SSS

Multiple cerebral and cerebellar abscesses

Empirical: IV MP and VM x 4 wks

Definitive: IV MP and P/O TMP-SMX x 2 wks f/b P/O DC and P/O TMP-SMX x 20 wks

Improved (20 wks)

Muthusamy et al. [7]

33 /M

Nil

SSS

Cerebral abscess, subdural collection and skull osteomyelitis

Craniectomy and drainage of the abscess f/b antibiotic treatment (NA)

Improved (52 wks)

Our case

51 /M

DM

Renal failure

TS

Multiple brain abscesses, skull osteomyelitis

Excision of the osteomyelitic occipital bone and antibiotic treatment as detailed in Table 1

Multiple recurrences

M Male, DM diabetes mellitus, CNS central nervous system, CVT cerebral venous sinus thrombosis, SSS superior sagittal sinus, TS transverse sinus, SS sigmoid sinus, CZ ceftazidime, TMP-SMX co-trimoxazole, MP meropenem, VM vancomycin, DC doxycycline, IV intravenous, P/O per oral, f/b followed by, FU follow up, wks weeks, data not available.

Cases of CM associated with CVT [4, 6–8] Author Age/sex Co-morbidities CVT location Other CNS involvement Treatment Outcome (FU wks) Niyasom et al. [8] 42 /M DM, liver cirrhosis SSS,TS, SS Parietal lobe infarct CZ x 2 wks Improved (2 wks) Nayak et al. [4] 23 /M Nil TS, SS, jugular vein Pachymeningeal thickening temporal region and petrous apex Biopsy f/b IV CZ x 6 wks f/b P/O TMP-SMX x 24 wks Improved (24 wks) Abeysundara et al. [6] 69 /M DM SSS Multiple cerebral and cerebellar abscesses Empirical: IV MP and VM x 4 wks Definitive: IV MP and P/O TMP-SMX x 2 wks f/b P/O DC and P/O TMP-SMX x 20 wks Improved (20 wks) Muthusamy et al. [7] 33 /M Nil SSS Cerebral abscess, subdural collection and skull osteomyelitis Craniectomy and drainage of the abscess f/b antibiotic treatment (NA) Improved (52 wks) Our case 51 /M DM Renal failure TS Multiple brain abscesses, skull osteomyelitis Excision of the osteomyelitic occipital bone and antibiotic treatment as detailed in Table 1 Multiple recurrences M Male, DM diabetes mellitus, CNS central nervous system, CVT cerebral venous sinus thrombosis, SSS superior sagittal sinus, TS transverse sinus, SS sigmoid sinus, CZ ceftazidime, TMP-SMX co-trimoxazole, MP meropenem, VM vancomycin, DC doxycycline, IV intravenous, P/O per oral, f/b followed by, FU follow up, wks weeks, data not available. Delay in diagnosis is a major concern in patients with melioidosis [1]. The clinical and radiological features of CM can mimic other CNS pathologies like tuberculosis [1, 4, 11], other pyogenic infections [11] or malignancies [1]. In our patient also there was a delay in diagnosis as the organism could not be isolated in the first two admissions. This made us treat him for a shorter duration than the recommended prolonged antibiotic treatment. However, after the recommended culturespecific treatment he was disease free for about 9 months. Cultures from the CNS specimen is the best way to establish a definite diagnosis of CM [12]. Diagnosis of the disease can also be done by culture of pus from the abscess [7], blood [6, 8] or involved tissues [4] demonstrating the growth of the organism. CSF pictures can be variable in patients with CM. It can show lymphocytic pleocytosis [2, 12], a CSF picture similar to tuberculosis or viral encephalitis. In about a third of patients, polymorphonuclear cell predominance can be seen [12] and rarely it can be acellular [6, 8]. CSF also demonstrates high protein and normal glucose [12]. However, in our case, the CSF study was normal and CSF culture was negative. The appropriate surgical intervention followed by antibiotic therapy is the recommended treatment for CM. The antibiotic of choice and its optimal duration of treatment are controversial [13]. Various authors recommend intravenous followed by oral antibiotic therapy in melioidosis. Duration of parenteral antibiotic therapy recommended by various authors ranges from 2 to 6 weeks [1-3] followed by oral antibiotics for 3–6 months [1, 3]. The parenteral antibiotics used are ceftazidime [2, 3] or meropenem [2]. Maintenance therapy with oral co-trimoxazole for 6 months following the initial parenteral antibiotic treatment has been recommended [1, 2, 4]. In patients who cannot tolerate co-trimoxazole, amoxicillin-clavulanate and/or doxycycline can be administered [3, 4]. The choice of antibiotic should be based on the culture and sensitivity. CVT in these patients is treated with intravenous anticoagulants [4, 8] along with antiepileptics [8]. Of the four previously reported cases of CM with CVT, all had good outcomes [4, 6–8]. When CM is seen associated with osteomyelitis or mass lesion, the mortality rate was about 25 % [1]. CM is known to recur due to non-compliance or suboptimal duration of antibiotic treatment [1]. We feel that the reasons for multiple recurrences and death in our case are (i) delay in diagnosis, (ii) inappropriate treatment due to lack of isolation of the organism during the initial two admissions, (iii) presence of co-morbidities like DM and renal failure and (iv) noncompliance to treatment.

Conclusion

Clinicians should be aware of this rare presentation of simultaneous CNS and systemic infection in association with CVT in patients with melioidosis. Through this article, we recommend the following in patients with clinical presentation similar to ours (i) consider CM as one of the differential diagnoses in patients presenting with intracranial lesion, (ii) consider performing MR venogram in these patients as CVT can rarely be associated, (iii) consider long-term recommended antibiotic therapy and (iv) keep these patients on close clinical and radiological follow-up. If cranial imaging shows recurrence of infection and bacterial cultures remain negative, these patients should be treated again with antibiotics based on previous positive cultures for the recommended period of time.
  11 in total

1.  Chronic pachymenigitis with dural venous sinus thrombosis: An unusual presentation of cranial melioidosis.

Authors:  Raghavendra Nayak; Bimal Patel; Krishnaprabhu Raju
Journal:  Neurol India       Date:  2018 Jul-Aug       Impact factor: 2.117

2.  Dural sinus thrombosis in melioidosis: the first case report.

Authors:  Suchada Niyasom; Pasiri Sithinamsuwan; Chesda Udommongkol; Jithanorm Suwantamee
Journal:  J Med Assoc Thai       Date:  2006-02

3.  Neurologic melioidosis presented as encephalomyelitis and subdural collection in two male labourers in India.

Authors:  Kavitha Saravu; Rajagopal Kadavigere; Ananthakrishna Barkur Shastry; Rohit Pai; Chiranjay Mukhopadhyay
Journal:  J Infect Dev Ctries       Date:  2015-11-30       Impact factor: 0.968

4.  Risk factors for melioidosis and bacteremic melioidosis.

Authors:  Y Suputtamongkol; W Chaowagul; P Chetchotisakd; N Lertpatanasuwun; S Intaranongpai; T Ruchutrakool; D Budhsarawong; P Mootsikapun; V Wuthiekanun; N Teerawatasook; A Lulitanond
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

5.  Cerebral melioidosis in Singapore: a review of five cases.

Authors:  D R Chadwick; B Ang; Y Y Sitoh; C C Lee
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Jan-Feb       Impact factor: 2.184

6.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

7.  Melioidosis with brain abscess.

Authors:  S Pit; F K Chea; F Jamal
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

8.  Spectra of central nervous system melioidosis.

Authors:  Kalai Arasu Muthusamy; Vicknes Waran; Savithri D Puthucheary
Journal:  J Clin Neurosci       Date:  2007-10-25       Impact factor: 1.961

Review 9.  Cranial melioidosis presenting as a mass lesion or osteomyelitis.

Authors:  G Samson Sujit Kumar; Promila Mohan Raj; Geeta Chacko; Mukkai K Lalitha; Ari G Chacko; Vedantam Rajshekhar
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

10.  Neurological melioidosis presenting as intracranial abscess.

Authors:  Deepak Madi; Santosh P V Rai; K Vidyalakshmi; K Nithyananda Chowta
Journal:  Indian J Pathol Microbiol       Date:  2016 Jul-Sep       Impact factor: 0.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.